Cargando…
T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices
BACKGROUND. A United Network for Organ Sharing policy change in 2015 created a 6-mo delay in the receipt of T2 hepatocellular carcinoma exception points. It was hypothesized that the policy changed locoregional therapy (LRT) practices and explant findings because of longer expected waiting time. MET...
Autores principales: | Durkin, Claire, Kaplan, David E., Bittermann, Therese |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447448/ https://www.ncbi.nlm.nih.gov/pubmed/32904026 http://dx.doi.org/10.1097/TXD.0000000000001039 |
Ejemplares similares
-
Magnetic Resonance Imaging Predictors of Hepatocellular Carcinoma Progression and Dropout in Patients in Liver Transplantation Waiting List
por: Baghdadi, Azarakhsh, et al.
Publicado: (2022) -
Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma
por: Shaikh, Anjiya, et al.
Publicado: (2022) -
A National Survey of Hepatocellular Carcinoma Surveillance Practices Following Liver Transplantation
por: Aggarwal, Avin, et al.
Publicado: (2020) -
Hyponatremia Is Associated With Increased Mortality in Children on the Waiting List for Liver Transplantation
por: Bezinover, Dmitri, et al.
Publicado: (2020) -
Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes
por: del Valle, Kathryn T., et al.
Publicado: (2022)